Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial

Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-28T10:20:26.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T00:10:04.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has updated its revision number from v2.14.4 to v2.15.0 and changed the date from 2025-01-20 to 2025-04-17.
    Difference
    2%
    Check dated 2025-04-22T18:00:51.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 20, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    1.0%
    Check dated 2025-04-08T09:15:31.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-03-03T13:35:15.000Z thumbnail image
  9. Check
    121 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T08:52:52.000Z thumbnail image

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.